Patients at Risk for Bleeding The elderly and patients with obesity are most affected by the increased bleeding risk when combining GLP-1R agonists with antithrombotic drugs such as aspirin, clopidogrel, or direct oral anticoagulants (DOACs)
Vomiting may follow, leading to rapid fluid loss and electrolyte depletion
MALDI-ToF analysis of polythiophene: use of trans-2-[3-(4-t-butyl-phenyl)-2-methyl- 2-propenylidene]malononitrile-DCTB-as matrix
In some cases, genetic testing may be required to identify underlying genetic disorders that affect carnitine metabolism or transport
Six-week-old male C57BL/6J mice were purchased from Orient Bio (Seongnam, Korea) and housed in a specific pathogen-free environment
With that in mind, here are some potential medications to discuss: Other GLP-1 receptor agonists: Ozempic belongs to a family of medications called GLP-1 medications